Posted inBiotechnology
Mussels Show Signs of Fear, Too
For a blue mussel, eating can be a dangerous business. The animal survives by filtering seawater through its body, extracting…
Posted inBiotechnology
Ultrafast Activation of Strong Coupling in a Semiconductor Terahertz Fabry-Pérot Cavity
A new study reports a way to switch on strong light–matter coupling inside a semiconductor terahertz cavity almost instantaneously, opening…
Posted inGenetics
Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis
Cancer metastasis is responsible for at least two-thirds of cancer deaths. Drugs targeting the metastatic progression have largely failed, in…
Posted inGenetics
Rare Immune Cell Type in Supercentenarians May Help Maintain Healthy Aging
Aging is accompanied by an increased risk of certain diseases, alongside weakened immunity to illnesses that younger individuals might easily…
Posted inBiotechnology
Baseline clinical features outperform MRI in predicting rapid cognitive-motor decline in Parkinson’s
Parkinson’s disease may be entering a new era of prediction, in which the earliest clues to a patient’s future are…
Posted inBiotechnology
Recurrent Cystitis Linked to Urologic Cancer Risk in Nationwide Study
A common bladder infection may be prompting a much bigger medical question than doctors once assumed. A nationwide population-based study…
Posted inBiotechnology
On-Chip Nonvolatile All-Optical Accelerator for Residual Neural Networks
Light could soon become more than a carrier of data. In a new study published in Light: Science & Applications,…
Posted inBiotechnology
Researchers uncover sex-based differences in liver structure and function
The liver has long been viewed as a broadly similar organ in men and women, with differences often attributed mainly…
Posted inBiotechnology
Scientists synthesize pyrroles from isoxazoles through oxygen-to-carbon skeletal editing
A single atom can determine whether a heterocycle is easy to build, difficult to modify, or inaccessible through conventional synthetic…
Posted inBiotechnology
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy
TScan has told Fierce that its pipeline strategy remains unchanged despite Amgen walking away from a Crohn’s disease collaboration that…